Skip to main content
. 2021 Jun 15;13(6):6662–6669.

Table 3.

The incidences of adverse reactions [n (%)]

RG (n=37) CG (n=35)
Infection 1 (2.70) 2 (5.71)
Osteomyelitis 0 (0.00) 0 (0.00)
Important vascular injury 0 (0.00) 1 (2.86)
Peripheral nerve injury 0 (0.00) 0 (0.00)
Ischemic muscle contracture 0 (0.00) 1 (2.86)
Fat embolism 0 (0.00) 0 (0.00)
Total incidence rate (%) 2.70% 11.43%